GL1X · GenesisL1 explorer

Research workbench

Crystal structure of rhodesain in complex with a macrolactam inhibitor

Analyse Crystal structure of rhodesain in complex with a macrolactam inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6EXO
Type
protein
Length
430 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cysteine protease
UniProt
Q95PM0
Ligands
C3E
Pockets
6 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCysteine proteaseprotein21527% helix, 23% strandQ95PM0

Ligands and binding sites

  • C3E · (3~{S},14~{E})-19-chloranyl-~{N}-(1-cyanocyclopropyl)-5-oxidanylidene-12,17-dioxa-4-azatricyclo[16.2.2.0^{6,11}]docosa-1(21),6(11),7,9,14,18(22),19-heptaene-3-carboxamide · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 23 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14730.780.8647EDO
2720.320.7518EDO
3640.320.7617C3E
4740.320.7418empty
5730.310.7423EDO

Interfaces

1 interface between chains.

  • A–B · 506 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 modified (disulfide, oxidation).

Compared structures

  • 6EXO · Crystal Structure of Rhodesain in complex with a Macrolactam Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.